EXHIBIT 31.1





CERTIFICATION PURSUANT TO RULES
13a-14(a) AND 15d-14(a), AS


ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002





Principal Executive
Officer





I, Xiaoqun Ye, Chief Executive Officer
of Kun Run Biotechnology, Inc., certify that:





1. I have reviewed this Quarterly Report
on Form 10-Q of Kun Run Biotechnology, Inc for the quarter endedJune 30, 2009;





2. Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to state a
material fact necessary to
make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this
report;





3. Based on my knowledge, the financial
statements, and other financial information included in this report, fairly present in
all material respects the financial condition, results of operations and cash
flows of theregistrantas of, and for, the periods presented
in this report;





4.  The registrant's other
certifying officer(s) and I areresponsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:





a)  Designedsuch disclosure controls and procedures,
or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant,
including its consolidated subsidiaries, is made known to us byothers within those entities,
particularly during the period in which this report is being
prepared;





b)  Designed such internal control
over financial reporting, or caused such internal control over financial
reporting to be designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with generally accepted
accounting principles;





c)  Evaluated the effectiveness of
the registrant's disclosure
controls and procedures and presented in this report our conclusions about the
effectiveness of the disclosure controls and procedures as of the end of the
period covered by this report based on such evaluation; and





d)  Disclosed in this report any change in the registrant's
internal control over financial reporting that occurred during the registrant's
most recent fiscal quarter that has materially affected, or is reasonably likely
to materially affect, the registrant's internal controlover financial reporting;
and





5. Theregistrant’s other certifying officer and I have
disclosed, based on our most recent evaluation of internal control over
financial reporting, to theregistrant’s auditors and the audit committee of
theregistrant’s board of directors (or persons performing
the equivalent functions);





a) All significant deficiencies and
material weaknesses in the design or operation of internal control over
financial reporting which are reasonably likely to adversely affect theregistrant’s ability to record, process, summarize
and report financial information; and




b) Any fraud, whether or not material,
that involves management or other employees who have a significant role in
theregistrant’s internal control over financial
reporting.




By:
                  /s/ Xiaoqun
    YeDated:August14, 2009Name: Xiaoqun
      YeTitle: Chief Executive
      Officer
                    (Principal Executive
      Officer)